Integration of quantitative proteomics data and interaction networks: Identification of dysregulated cellular functions during cancer progression.

Quantitative proteomics allows the characterization of molecular changes between healthy and disease states. To interpret such datasets, their integration to the protein-protein interaction network provides a more comprehensive understanding of cellular function dysregulation in diseases than just considering lists of dysregulated proteins. Here, we propose a novel computational method, which combines protein interaction network and statistical analyses to establish expression profiles at the network module level rather than at the individual protein level, and to detect and characterize dysregulated network modules through different stages of cancer progression. We applied our approach to two publicly available datasets as case studies.

[1]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[2]  Karin Breuer,et al.  InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation , 2012, Nucleic Acids Res..

[3]  P. Aloy,et al.  A network medicine approach to human disease , 2009, FEBS letters.

[4]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[5]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[6]  Kwanghee Kim,et al.  Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment , 2010, Breast Cancer Research.

[7]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Zhengwei Zhu,et al.  CD-HIT: accelerated for clustering the next-generation sequencing data , 2012, Bioinform..

[9]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[10]  F. Pajonk,et al.  Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression , 2013, Breast Cancer Research and Treatment.

[11]  R. Tibshirani,et al.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Jeffrey R. Whiteaker,et al.  Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.

[13]  L. Furlong Human diseases through the lens of network biology. , 2013, Trends in genetics : TIG.

[14]  Q. Dou,et al.  Targeting the ubiquitin–proteasome system for cancer therapy , 2013, Expert opinion on therapeutic targets.

[15]  P. Mischel,et al.  Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients , 2014, BMC Cancer.

[16]  Durga Prasad Mishra,et al.  Therapeutic targeting of cancer cell cycle using proteasome inhibitors , 2012, Cell Division.

[17]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[18]  K. Basso,et al.  A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas , 2008, Molecular systems biology.

[19]  C. Overall,et al.  TopFIND, a knowledgebase linking protein termini with function , 2011, Nature Methods.

[20]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[21]  Lajos Pusztai,et al.  Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data? , 2010, Genome Medicine.

[22]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[23]  Alain Guénoche,et al.  Multifunctional proteins revealed by overlapping clustering in protein interaction network , 2011, Bioinform..

[24]  Matthias Mann,et al.  Proteomic portrait of human breast cancer progression identifies novel prognostic markers. , 2012, Cancer research.

[25]  Lionel Spinelli,et al.  Extreme multifunctional proteins identified from a human protein interaction network , 2015, Nature Communications.

[26]  Kenneth H. Buetow,et al.  PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..

[27]  Sylvie Ricard-Blum,et al.  MatrixDB, the extracellular matrix interaction database , 2010, Nucleic Acids Res..

[28]  Ron Shamir,et al.  SPIKE – a database, visualization and analysis tool of cellular signaling pathways , 2008, BMC Bioinformatics.

[29]  Giorgio Valle,et al.  The Gene Ontology in 2010: extensions and refinements , 2009, Nucleic Acids Res..

[30]  Luis Serrano,et al.  Correlation of mRNA and protein in complex biological samples , 2009, FEBS letters.

[31]  Ioannis Xenarios,et al.  DIP: The Database of Interacting Proteins: 2001 update , 2001, Nucleic Acids Res..

[32]  E. Schadt Molecular networks as sensors and drivers of common human diseases , 2009, Nature.

[33]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[34]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[35]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[36]  Subha Madhavan,et al.  The CPTAC Data Portal: A Resource for Cancer Proteomics Research. , 2015, Journal of proteome research.

[37]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[38]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Mann,et al.  Quantitative, high-resolution proteomics for data-driven systems biology. , 2011, Annual review of biochemistry.

[40]  M. You,et al.  26S Proteasome Activity Is Down-Regulated in Lung Cancer Stem-Like Cells Propagated In Vitro , 2010, PloS one.

[41]  I. Ellis,et al.  A gene-expression signature to predict survival in breast cancer across independent data sets , 2007, Oncogene.

[42]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[43]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[44]  P. Aloy,et al.  Interactome3D: adding structural details to protein networks , 2013, Nature Methods.

[45]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[46]  Andrew Chatr-aryamontri,et al.  Structural and functional protein network analyses predict novel signaling functions for rhodopsin , 2011, Molecular systems biology.

[47]  L. Crawford,et al.  Proteasome inhibitors in cancer therapy , 2011, Journal of Cell Communication and Signaling.

[48]  Carlos Prieto,et al.  APID: Agile Protein Interaction DataAnalyzer , 2006, Nucleic Acids Res..

[49]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Clara Pizzuti,et al.  Algorithms and tools for protein-protein interaction networks clustering, with a special focus on population-based stochastic methods , 2014, Bioinform..

[51]  R. Schwabe,et al.  The Yin and Yang of Toll-like receptors in cancer , 2014, Oncogene.

[52]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[53]  Gary D Bader,et al.  PSICQUIC and PSISCORE: accessing and scoring molecular interactions , 2011, Nature Methods.

[54]  E. Marcotte,et al.  Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entry , 2012, Molecular systems biology.

[55]  E. Gelmann,et al.  The ubiquitin-proteasome pathway and its role in cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  Kara Dolinski,et al.  The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..

[57]  Adam J. Smith,et al.  The Database of Interacting Proteins: 2004 update , 2004, Nucleic Acids Res..

[58]  Rachael P. Huntley,et al.  The GOA database in 2009—an integrated Gene Ontology Annotation resource , 2008, Nucleic Acids Res..